nodes	percent_of_prediction	percent_of_DWPC	metapath
Leflunomide—CYP1A2—Thalidomide—leprosy	0.169	0.224	CbGbCtD
Leflunomide—CYP1A2—Rifampicin—leprosy	0.163	0.217	CbGbCtD
Leflunomide—CYP2C9—Thalidomide—leprosy	0.152	0.202	CbGbCtD
Leflunomide—CYP2C9—Rifampicin—leprosy	0.147	0.196	CbGbCtD
Leflunomide—CYP2C9—Dapsone—leprosy	0.121	0.161	CbGbCtD
Leflunomide—Acquired immunodeficiency syndrome—Thalidomide—leprosy	0.00996	0.0402	CcSEcCtD
Leflunomide—Autoimmune disorder—Thalidomide—leprosy	0.00599	0.0242	CcSEcCtD
Leflunomide—Albuminuria—Dapsone—leprosy	0.00523	0.0211	CcSEcCtD
Leflunomide—Fungal skin infection—Thalidomide—leprosy	0.00479	0.0193	CcSEcCtD
Leflunomide—Raised liver function tests—Thalidomide—leprosy	0.00433	0.0175	CcSEcCtD
Leflunomide—Hernia—Thalidomide—leprosy	0.00426	0.0172	CcSEcCtD
Leflunomide—Aphthous stomatitis—Thalidomide—leprosy	0.00426	0.0172	CcSEcCtD
Leflunomide—Lactic dehydrogenase activity increased—Thalidomide—leprosy	0.00391	0.0158	CcSEcCtD
Leflunomide—Foetor hepaticus—Thalidomide—leprosy	0.00352	0.0142	CcSEcCtD
Leflunomide—Blood lactate dehydrogenase increased—Thalidomide—leprosy	0.00344	0.0139	CcSEcCtD
Leflunomide—Psoriasis—Thalidomide—leprosy	0.00318	0.0128	CcSEcCtD
Leflunomide—Oral candidiasis—Thalidomide—leprosy	0.00315	0.0127	CcSEcCtD
Leflunomide—Nail disorder—Thalidomide—leprosy	0.00308	0.0124	CcSEcCtD
Leflunomide—Tooth disorder—Thalidomide—leprosy	0.00308	0.0124	CcSEcCtD
Leflunomide—Menstrual disorder—Thalidomide—leprosy	0.00293	0.0118	CcSEcCtD
Leflunomide—Liver disorder—Thalidomide—leprosy	0.00293	0.0118	CcSEcCtD
Leflunomide—Neuralgia—Thalidomide—leprosy	0.00288	0.0116	CcSEcCtD
Leflunomide—Interstitial lung disease—Thalidomide—leprosy	0.00282	0.0114	CcSEcCtD
Leflunomide—Hyperlipidaemia—Thalidomide—leprosy	0.00277	0.0112	CcSEcCtD
Leflunomide—Albuminuria—Thalidomide—leprosy	0.00268	0.0108	CcSEcCtD
Leflunomide—Neuritis—Thalidomide—leprosy	0.00268	0.0108	CcSEcCtD
Leflunomide—Cholestasis—Thalidomide—leprosy	0.00263	0.0106	CcSEcCtD
Leflunomide—Amblyopia—Thalidomide—leprosy	0.00259	0.0104	CcSEcCtD
Leflunomide—Skin ulcer—Thalidomide—leprosy	0.00257	0.0104	CcSEcCtD
Leflunomide—Tingling sensation—Thalidomide—leprosy	0.00249	0.01	CcSEcCtD
Leflunomide—Influenza—Dapsone—leprosy	0.00245	0.00989	CcSEcCtD
Leflunomide—Endocrine disorder—Thalidomide—leprosy	0.00241	0.00973	CcSEcCtD
Leflunomide—Pancreatitis—Dapsone—leprosy	0.0024	0.00969	CcSEcCtD
Leflunomide—Blood disorder—Thalidomide—leprosy	0.00239	0.00966	CcSEcCtD
Leflunomide—Acne—Thalidomide—leprosy	0.00238	0.00959	CcSEcCtD
Leflunomide—Vasodilation—Thalidomide—leprosy	0.00227	0.00918	CcSEcCtD
Leflunomide—Vasodilation procedure—Thalidomide—leprosy	0.00227	0.00918	CcSEcCtD
Leflunomide—Skin discolouration—Thalidomide—leprosy	0.00221	0.00893	CcSEcCtD
Leflunomide—Arthropathy—Thalidomide—leprosy	0.0022	0.00887	CcSEcCtD
Leflunomide—Herpes simplex—Thalidomide—leprosy	0.00217	0.00875	CcSEcCtD
Leflunomide—Neuropathy peripheral—Dapsone—leprosy	0.00214	0.00864	CcSEcCtD
Leflunomide—Bone pain—Thalidomide—leprosy	0.00209	0.00842	CcSEcCtD
Leflunomide—Sinusitis—Dapsone—leprosy	0.00205	0.00827	CcSEcCtD
Leflunomide—Neck pain—Thalidomide—leprosy	0.00202	0.00816	CcSEcCtD
Leflunomide—Hepatocellular injury—Thalidomide—leprosy	0.002	0.00807	CcSEcCtD
Leflunomide—Pharyngitis—Dapsone—leprosy	0.00195	0.00785	CcSEcCtD
Leflunomide—Colitis—Thalidomide—leprosy	0.00192	0.00775	CcSEcCtD
Leflunomide—Candida infection—Thalidomide—leprosy	0.00191	0.0077	CcSEcCtD
Leflunomide—Cramps of lower extremities—Thalidomide—leprosy	0.00184	0.00741	CcSEcCtD
Leflunomide—Oesophagitis—Thalidomide—leprosy	0.00183	0.00737	CcSEcCtD
Leflunomide—Rash maculo-papular—Thalidomide—leprosy	0.00182	0.00733	CcSEcCtD
Leflunomide—Sepsis—Thalidomide—leprosy	0.00173	0.007	CcSEcCtD
Leflunomide—Lymphadenopathy—Thalidomide—leprosy	0.0017	0.00686	CcSEcCtD
Leflunomide—Diabetes mellitus—Thalidomide—leprosy	0.00167	0.00673	CcSEcCtD
Leflunomide—Gastroenteritis—Thalidomide—leprosy	0.00164	0.00661	CcSEcCtD
Leflunomide—Eczema—Thalidomide—leprosy	0.00161	0.00652	CcSEcCtD
Leflunomide—Vision blurred—Dapsone—leprosy	0.00161	0.00649	CcSEcCtD
Leflunomide—Vertigo—Dapsone—leprosy	0.00153	0.00619	CcSEcCtD
Leflunomide—Arthritis—Thalidomide—leprosy	0.00149	0.00603	CcSEcCtD
Leflunomide—Cough—Dapsone—leprosy	0.00149	0.00601	CcSEcCtD
Leflunomide—Osteoarthritis—Thalidomide—leprosy	0.00145	0.00586	CcSEcCtD
Leflunomide—Migraine—Thalidomide—leprosy	0.00143	0.00576	CcSEcCtD
Leflunomide—Tachycardia—Dapsone—leprosy	0.00136	0.00549	CcSEcCtD
Leflunomide—Liver function test abnormal—Thalidomide—leprosy	0.00134	0.00541	CcSEcCtD
Leflunomide—Dry skin—Thalidomide—leprosy	0.00133	0.00537	CcSEcCtD
Leflunomide—Hypokalaemia—Thalidomide—leprosy	0.00132	0.00533	CcSEcCtD
Leflunomide—Breast disorder—Thalidomide—leprosy	0.00131	0.00529	CcSEcCtD
Leflunomide—Cramp muscle—Thalidomide—leprosy	0.00131	0.00527	CcSEcCtD
Leflunomide—Toxic epidermal necrolysis—Thalidomide—leprosy	0.00131	0.00527	CcSEcCtD
Leflunomide—Insomnia—Dapsone—leprosy	0.00126	0.00508	CcSEcCtD
Leflunomide—Influenza—Thalidomide—leprosy	0.00125	0.00506	CcSEcCtD
Leflunomide—Eosinophilia—Thalidomide—leprosy	0.00124	0.00501	CcSEcCtD
Leflunomide—Pancreatitis—Thalidomide—leprosy	0.00123	0.00496	CcSEcCtD
Leflunomide—Angina pectoris—Thalidomide—leprosy	0.00122	0.00493	CcSEcCtD
Leflunomide—Bronchitis—Thalidomide—leprosy	0.00121	0.00487	CcSEcCtD
Leflunomide—Pancytopenia—Thalidomide—leprosy	0.00119	0.00481	CcSEcCtD
Leflunomide—Neutropenia—Thalidomide—leprosy	0.00117	0.00473	CcSEcCtD
Leflunomide—Upper respiratory tract infection—Thalidomide—leprosy	0.00117	0.0047	CcSEcCtD
Leflunomide—Pollakiuria—Thalidomide—leprosy	0.00116	0.00468	CcSEcCtD
Leflunomide—Gastrointestinal pain—Dapsone—leprosy	0.00114	0.0046	CcSEcCtD
Leflunomide—Weight decreased—Thalidomide—leprosy	0.00113	0.00458	CcSEcCtD
Leflunomide—Hyperglycaemia—Thalidomide—leprosy	0.00113	0.00457	CcSEcCtD
Leflunomide—Pneumonia—Thalidomide—leprosy	0.00112	0.00454	CcSEcCtD
Leflunomide—Infestation NOS—Thalidomide—leprosy	0.00112	0.00451	CcSEcCtD
Leflunomide—Infestation—Thalidomide—leprosy	0.00112	0.00451	CcSEcCtD
Leflunomide—Stevens-Johnson syndrome—Thalidomide—leprosy	0.00111	0.00447	CcSEcCtD
Leflunomide—Abdominal pain—Dapsone—leprosy	0.0011	0.00444	CcSEcCtD
Leflunomide—Body temperature increased—Dapsone—leprosy	0.0011	0.00444	CcSEcCtD
Leflunomide—Renal failure—Thalidomide—leprosy	0.0011	0.00444	CcSEcCtD
Leflunomide—Neuropathy peripheral—Thalidomide—leprosy	0.0011	0.00442	CcSEcCtD
Leflunomide—Stomatitis—Thalidomide—leprosy	0.00109	0.0044	CcSEcCtD
Leflunomide—Conjunctivitis—Thalidomide—leprosy	0.00109	0.00439	CcSEcCtD
Leflunomide—Haematuria—Thalidomide—leprosy	0.00107	0.0043	CcSEcCtD
Leflunomide—Epistaxis—Thalidomide—leprosy	0.00105	0.00426	CcSEcCtD
Leflunomide—Sinusitis—Thalidomide—leprosy	0.00105	0.00423	CcSEcCtD
Leflunomide—Agranulocytosis—Thalidomide—leprosy	0.00104	0.00421	CcSEcCtD
Leflunomide—Rhinitis—Thalidomide—leprosy	0.00101	0.00406	CcSEcCtD
Leflunomide—Hepatitis—Thalidomide—leprosy	0.001	0.00405	CcSEcCtD
Leflunomide—Pharyngitis—Thalidomide—leprosy	0.000996	0.00402	CcSEcCtD
Leflunomide—Urinary tract disorder—Thalidomide—leprosy	0.000991	0.004	CcSEcCtD
Leflunomide—Oedema peripheral—Thalidomide—leprosy	0.000989	0.00399	CcSEcCtD
Leflunomide—Urethral disorder—Thalidomide—leprosy	0.000984	0.00397	CcSEcCtD
Leflunomide—Erythema multiforme—Thalidomide—leprosy	0.000949	0.00383	CcSEcCtD
Leflunomide—Eye disorder—Thalidomide—leprosy	0.000938	0.00379	CcSEcCtD
Leflunomide—Cardiac disorder—Thalidomide—leprosy	0.000932	0.00376	CcSEcCtD
Leflunomide—Immune system disorder—Thalidomide—leprosy	0.000907	0.00366	CcSEcCtD
Leflunomide—Mediastinal disorder—Thalidomide—leprosy	0.000905	0.00365	CcSEcCtD
Leflunomide—Chills—Thalidomide—leprosy	0.000901	0.00363	CcSEcCtD
Leflunomide—Arrhythmia—Thalidomide—leprosy	0.000897	0.00362	CcSEcCtD
Leflunomide—Alopecia—Thalidomide—leprosy	0.000887	0.00358	CcSEcCtD
Leflunomide—Vomiting—Dapsone—leprosy	0.000886	0.00357	CcSEcCtD
Leflunomide—Mental disorder—Thalidomide—leprosy	0.000879	0.00355	CcSEcCtD
Leflunomide—Malnutrition—Thalidomide—leprosy	0.000874	0.00353	CcSEcCtD
Leflunomide—Headache—Dapsone—leprosy	0.000873	0.00352	CcSEcCtD
Leflunomide—Flatulence—Thalidomide—leprosy	0.000861	0.00347	CcSEcCtD
Leflunomide—Dysgeusia—Thalidomide—leprosy	0.000856	0.00345	CcSEcCtD
Leflunomide—Back pain—Thalidomide—leprosy	0.000845	0.00341	CcSEcCtD
Leflunomide—Muscle spasms—Thalidomide—leprosy	0.00084	0.00339	CcSEcCtD
Leflunomide—Nausea—Dapsone—leprosy	0.000827	0.00334	CcSEcCtD
Leflunomide—Vision blurred—Thalidomide—leprosy	0.000823	0.00332	CcSEcCtD
Leflunomide—Ill-defined disorder—Thalidomide—leprosy	0.000811	0.00327	CcSEcCtD
Leflunomide—Anaemia—Thalidomide—leprosy	0.000808	0.00326	CcSEcCtD
Leflunomide—Angioedema—Thalidomide—leprosy	0.000798	0.00322	CcSEcCtD
Leflunomide—Malaise—Thalidomide—leprosy	0.000788	0.00318	CcSEcCtD
Leflunomide—Vertigo—Thalidomide—leprosy	0.000785	0.00317	CcSEcCtD
Leflunomide—Leukopenia—Thalidomide—leprosy	0.000782	0.00316	CcSEcCtD
Leflunomide—Palpitations—Thalidomide—leprosy	0.000772	0.00312	CcSEcCtD
Leflunomide—Cough—Thalidomide—leprosy	0.000762	0.00308	CcSEcCtD
Leflunomide—Hypertension—Thalidomide—leprosy	0.000754	0.00304	CcSEcCtD
Leflunomide—Arthralgia—Thalidomide—leprosy	0.000744	0.003	CcSEcCtD
Leflunomide—Chest pain—Thalidomide—leprosy	0.000744	0.003	CcSEcCtD
Leflunomide—Myalgia—Thalidomide—leprosy	0.000744	0.003	CcSEcCtD
Leflunomide—Anxiety—Thalidomide—leprosy	0.000741	0.00299	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000739	0.00298	CcSEcCtD
Leflunomide—Discomfort—Thalidomide—leprosy	0.000735	0.00297	CcSEcCtD
Leflunomide—Dry mouth—Thalidomide—leprosy	0.000728	0.00294	CcSEcCtD
Leflunomide—Infection—Thalidomide—leprosy	0.000708	0.00286	CcSEcCtD
Leflunomide—Nervous system disorder—Thalidomide—leprosy	0.000699	0.00282	CcSEcCtD
Leflunomide—Thrombocytopenia—Thalidomide—leprosy	0.000698	0.00282	CcSEcCtD
Leflunomide—Tachycardia—Thalidomide—leprosy	0.000696	0.00281	CcSEcCtD
Leflunomide—Skin disorder—Thalidomide—leprosy	0.000693	0.0028	CcSEcCtD
Leflunomide—Hyperhidrosis—Thalidomide—leprosy	0.000689	0.00278	CcSEcCtD
Leflunomide—Anorexia—Thalidomide—leprosy	0.00068	0.00274	CcSEcCtD
Leflunomide—Hypotension—Thalidomide—leprosy	0.000666	0.00269	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Thalidomide—leprosy	0.00065	0.00262	CcSEcCtD
Leflunomide—Insomnia—Thalidomide—leprosy	0.000645	0.0026	CcSEcCtD
Leflunomide—Paraesthesia—Thalidomide—leprosy	0.00064	0.00258	CcSEcCtD
Leflunomide—Dyspnoea—Thalidomide—leprosy	0.000636	0.00257	CcSEcCtD
Leflunomide—Dyspepsia—Thalidomide—leprosy	0.000628	0.00253	CcSEcCtD
Leflunomide—Decreased appetite—Thalidomide—leprosy	0.00062	0.0025	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Thalidomide—leprosy	0.000616	0.00248	CcSEcCtD
Leflunomide—Fatigue—Thalidomide—leprosy	0.000615	0.00248	CcSEcCtD
Leflunomide—Pain—Thalidomide—leprosy	0.00061	0.00246	CcSEcCtD
Leflunomide—Constipation—Thalidomide—leprosy	0.00061	0.00246	CcSEcCtD
Leflunomide—Feeling abnormal—Thalidomide—leprosy	0.000588	0.00237	CcSEcCtD
Leflunomide—Gastrointestinal pain—Thalidomide—leprosy	0.000583	0.00235	CcSEcCtD
Leflunomide—Urticaria—Thalidomide—leprosy	0.000566	0.00229	CcSEcCtD
Leflunomide—Abdominal pain—Thalidomide—leprosy	0.000564	0.00228	CcSEcCtD
Leflunomide—Body temperature increased—Thalidomide—leprosy	0.000564	0.00228	CcSEcCtD
Leflunomide—Hypersensitivity—Thalidomide—leprosy	0.000525	0.00212	CcSEcCtD
Leflunomide—Asthenia—Thalidomide—leprosy	0.000512	0.00206	CcSEcCtD
Leflunomide—Pruritus—Thalidomide—leprosy	0.000505	0.00204	CcSEcCtD
Leflunomide—Diarrhoea—Thalidomide—leprosy	0.000488	0.00197	CcSEcCtD
Leflunomide—Dizziness—Thalidomide—leprosy	0.000472	0.0019	CcSEcCtD
Leflunomide—Vomiting—Thalidomide—leprosy	0.000453	0.00183	CcSEcCtD
Leflunomide—Rash—Thalidomide—leprosy	0.00045	0.00181	CcSEcCtD
Leflunomide—Dermatitis—Thalidomide—leprosy	0.000449	0.00181	CcSEcCtD
Leflunomide—Headache—Thalidomide—leprosy	0.000447	0.0018	CcSEcCtD
Leflunomide—Nausea—Thalidomide—leprosy	0.000424	0.00171	CcSEcCtD
